| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 08/17/2011 | CN1787741B Methods and compositions for the prevention and treatment of sepsis |
| 08/17/2011 | CN1681845B Therapeutic uses of monoclonal antibodies to the angiotensin-II type-1 receptor |
| 08/17/2011 | CN102159592A Antibody complex, antigen detection method, and method for production of antibody complex |
| 08/17/2011 | CN102159591A Monoclonal antibody, and immunoassay using same |
| 08/17/2011 | CN102159590A Compositions monovalent for cd28 binding and methods of use |
| 08/17/2011 | CN102159243A Structural variants of antibodies for improved therapeutic characteristics |
| 08/17/2011 | CN102159194A Novel antibody formulation |
| 08/17/2011 | CN102154259A Preparation method and use of genetic engineering preparation for dissolving blood platelet thrombi |
| 08/17/2011 | CN102154218A Hybridoma cell strain 4e9 and monoclonal antibody produced by using hybridoma cell strain 4e9 |
| 08/17/2011 | CN102154217A Recombinant chicken osteocalcin maturation protein monoclonal antibody and application thereof |
| 08/17/2011 | CN102154216A Anti-creatine kinase M (CKM) monoclonal antibody, hybridoma cell line producing same and use thereof |
| 08/17/2011 | CN102154215A Monoclonal antibody of chicken infectious laryngotracheitis virus gJ protein and application thereof |
| 08/17/2011 | CN102153651A Anti-dextran single-chain antibody and preparation method of anti-dextran single-chain antibody |
| 08/17/2011 | CN102153650A Anti-EGFR (epidemic growth factor receptor) humanized antibody L2-H3 and coding gene and application thereof |
| 08/17/2011 | CN102153649A Anti-epidemic growth factor receptor (EGFR) humanized antibody L1-H3 and coded gene and application thereof |
| 08/17/2011 | CN102153648A EGFR (epidermal growth factor receptor)-inhibiting humanized antibody L4-H3 and encoding genes and application thereof |
| 08/17/2011 | CN102153647A Anti-EGFR (epidemic growth factor receptor) humanized antibody L3-H3 and coding gene and application thereof |
| 08/17/2011 | CN102153632A Antibody of escherichia coli resistant TolC tricosanoic peptide and application |
| 08/17/2011 | CN102153628A Alpha1-antitrypsin polyclonal antibody and application of alpha1-antitrypsin polyclonal antibody and polypeptide for alpha1-antitrypsin polyclonal antibody |
| 08/17/2011 | CN102151334A Antibody against a tumor-specific antigen as target |
| 08/17/2011 | CN101503471B Monoclonal antibody of anti-rhabdovirus glucoprotein of mandarin fish, preparation and use thereof |
| 08/17/2011 | CN101348526B Anti-interleukin-8 antibody |
| 08/17/2011 | CN101074264B Recombinant anti-CTLA4 monoclonal antibody, its production and use |
| 08/16/2011 | US7999161 Selective thermomechanical damage to a biological body such as a cancer cell or cell associated with a pathophysiological condition; cancer cell is specifically targeted with nanoparticulates; pulsed electromagnetic radiation; leukemia |
| 08/16/2011 | US7999083 Immunoconjugates with an intracellularly-cleavable linkage |
| 08/16/2011 | US7999082 monoclonal antibodies or antigen-binding fragments used to reduce or prevent respiratory system hyperresponsiveness and/or inflammation; treatment of respiratory system disorders |
| 08/16/2011 | US7999081 Anti-C5 alpha antibodies |
| 08/16/2011 | US7999080 Reagents for the detection of protein phosphorylation in signaling pathways |
| 08/16/2011 | US7999079 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins |
| 08/16/2011 | US7999078 Antibodies that bind DNAX leukocyte associated immunoglobulin-like receptor |
| 08/16/2011 | US7999077 IRTA2 antibodies and methods of use |
| 08/16/2011 | US7999071 vector-based vaccine may well aid in the development of effective vaccines for a range of human cancers; nucleic acid; agonist polypeptide derived from a mucin tumor antigen; genetic vaccine |
| 08/16/2011 | US7998960 Affinity adsorbents for plasminogen |
| 08/16/2011 | US7998931 Vascular endothelial cell growth factor antagonists and uses thereof |
| 08/16/2011 | US7998924 Compounds that bind to p185 and methods of using the same |
| 08/16/2011 | US7998738 Integrin-binding antibodies |
| 08/16/2011 | US7998737 Cell culture of keratinocytes under non-differentiating conditions |
| 08/16/2011 | US7998691 Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor |
| 08/16/2011 | US7998682 Method for assessing atherosclerosis by measuring expression of FOS or DUSP1 in monocytes |
| 08/16/2011 | US7998681 Detection of graves' disease or rheumatoid arthritis in humans; obtain sample, incubate with immunoglobulins, detect signal, measure signal compare to control, amplified signal indicates graves or arthritic disorders |
| 08/16/2011 | US7998680 Determining genotype of a polymorphic site in the hereditary hemochromatosis gene |
| 08/16/2011 | US7998491 Polypeptide ESDN, polynucleotides encoding the polypeptide, and utility of the polypeptide |
| 08/16/2011 | US7998479 Substance specific to human PD-1 |
| 08/16/2011 | US7998478 Pharmaceutical composition for treating immune diseases |
| 08/16/2011 | US7998477 Spherical protein particles and methods for making and using them |
| 08/16/2011 | CA2615061C Peptide for antibody radio-labeling |
| 08/16/2011 | CA2507716C Novel adaptor protein that binds to mammalian toll-like receptor 3, and gene thereof |
| 08/16/2011 | CA2456648C Human antibodies specific for interleukin 15 (il-15) |
| 08/16/2011 | CA2451608C Process for constructing a mutant utilizing the igh 3' enhancer |
| 08/16/2011 | CA2405450C Dermacentor variabilis gaba-gated chloride channels |
| 08/16/2011 | CA2389979C Methods of inhibiting metastasis |
| 08/16/2011 | CA2354325C Growth factor homolog zvegf3 |
| 08/16/2011 | CA2174928C Compositions that specifically bind to colorectal cancer cells and methods of using the same |
| 08/11/2011 | WO2011097609A1 Model system of acanthamoeba keratitis syndrome and method for selecting a treatment thereof |
| 08/11/2011 | WO2011097603A1 Common light chain mouse |
| 08/11/2011 | WO2011097500A2 The tweak/fn14 system regulates skeletal muscle atrophy and regeneration |
| 08/11/2011 | WO2011096698A2 Composition for cancer prognosis prediction comprising anti-tmap/ckap2 antibodies |
| 08/11/2011 | WO2011096535A1 Pharmaceutical agent for treatment and/or prevention of cancer |
| 08/11/2011 | WO2011096534A1 Pharmaceutical composition for treatment and/or prevention of cancer |
| 08/11/2011 | WO2011096533A1 Pharmaceutical composition for treatment and/or prevention of cancer |
| 08/11/2011 | WO2011096528A1 Pharmaceutical composition for treatment and/or prevention of cancer |
| 08/11/2011 | WO2011096519A1 Medicinal composition for treating and/or preventing cancer |
| 08/11/2011 | WO2011096517A1 Pharmaceutical composition for treatment and/or prevention of cancer |
| 08/11/2011 | WO2011096302A1 Antibody specific to drug-resistant influenza virus and use of same |
| 08/11/2011 | WO2011095592A1 In vitro process for the preparation of antibodies of the igg type |
| 08/11/2011 | WO2011095545A1 Peptides capable of binding to serum albumin and compounds, constructs and polypeptides comprising the same |
| 08/11/2011 | WO2011095506A1 Process for obtaining antibodies |
| 08/11/2011 | WO2011095498A1 A monoclonal antibody to cd44 for use in the treatment of head and neck squamous cell carcinoma |
| 08/11/2011 | WO2011064257A3 Monospecific polypeptide reagents |
| 08/11/2011 | WO2011004028A9 Tlr3 binding agents |
| 08/11/2011 | WO2006045308A8 Chlamydia trachomatis antigens for vaccine and diagnostic use |
| 08/11/2011 | US20110197292 Delivery method |
| 08/11/2011 | US20110196128 Murine zcytor17 ligand polynucleotides |
| 08/11/2011 | US20110195911 Synthetic analogs of the juxtamembrane domain of igf1r and uses thereof |
| 08/11/2011 | US20110195901 Artery- and vein-specific proteins and uses therefor |
| 08/11/2011 | US20110195843 Plants with Increased Yield (LT) |
| 08/11/2011 | US20110195509 Treatment of th17-mediated autoimmune disease via inhibition of stat 3 |
| 08/11/2011 | US20110195494 Dll4-binging molecules |
| 08/11/2011 | US20110195479 Polymerase |
| 08/11/2011 | US20110195478 Bladder cancer biomarker and test method using the same |
| 08/11/2011 | US20110195456 Methods and compositions for the production of monoclonal antibodies |
| 08/11/2011 | US20110195453 Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization |
| 08/11/2011 | US20110195438 Insulin assay |
| 08/11/2011 | US20110195428 Composition, kit, and method for assaying ageing and disease accompanied with vascular disorder |
| 08/11/2011 | US20110195409 Streptococcus pyogenes classification |
| 08/11/2011 | US20110195407 Nucleic acid occurring in blood from hepatitis patient, polypeptide encoded by the nucleic acid, and uses of the same |
| 08/11/2011 | US20110195084 Anti-HIV Vaccine Constructed Based on Amino Acid Mutations in Attenuated Live EIAV Vaccine |
| 08/11/2011 | US20110195081 Foxm1 peptide and medicinal agent comprising the same |
| 08/11/2011 | US20110195076 Therapeutic agent |
| 08/11/2011 | US20110195074 Ephrin Type-A Receptor 7 Protein |
| 08/11/2011 | US20110195072 Non-neuroendocrine cancer therapy |
| 08/11/2011 | US20110195069 Inhibitors of complement activation |
| 08/11/2011 | US20110195068 Pd-1 antagonists and methods of use thereof |
| 08/11/2011 | US20110195067 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW AFFINITY FCy RECEPTORS |
| 08/11/2011 | US20110195063 Methods of Treating Ankylosing Spondylitis Using Anti-TNF Antibodies and Peptides of Human Tumor Necrosis Factor |
| 08/11/2011 | US20110195062 Mammalian Cytokines; Related Reagents and Methods |
| 08/11/2011 | US20110195048 Regulation of lymphocytes and uses therefor |
| 08/11/2011 | US20110195027 Cd9-specific human antibodies |
| 08/11/2011 | US20110195026 Protein |
| 08/11/2011 | US20110195023 Internalizing Anti-CD74 Antibodies and Methods of Use |